Literature DB >> 12535746

High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study.

Shicheng Yu1, John W G Yarnell, Peter Sweetnam, Colin H Bolton.   

Abstract

Whether the protective effect of high density lipoprotein (HDL) on incident coronary heart disease (CHD) can be attributed to one or both HDL subfractions remains controversial. The associations of HDL(2) and HDL(3) cholesterol with the incidence of CHD in the 9-year follow-up of the Caerphilly study are described. A total of 2398 middle-aged British men were recruited from the general population between 1984 and 1988 and were followed, on average, for 9 years. Total and HDL(3) cholesterol were measured by a two-step precipitation technique on fresh, fasting samples from 2225 men. HDL(2) cholesterol was calculated by subtracting HDL(3) from total HDL cholesterol. Relative odds and 95% confidence intervals (CI) for incident CHD were obtained by use of a logistic regression model. During follow-up, 282 (12%) men developed a major new CHD event. Total HDL and HDL(3) cholesterol were significantly and inversely associated with the risk of incident CHD. When divided into fifths of the distributions of total HDL and HDL(3) cholesterol, multivariate-adjusted relative odds were 1.00, 0.95, 0.72, 0.85, 0.38 and 1.00, 1.05, 0.92, 0.67, 0.39, respectively graded from the least to the most quintile, with the lowest quintile group as referent. Tests for trend were significant (P for trend 0.003 and 0.001, respectively). In a multivariate model, the contribution of HDL(3) was significant (standardized relative odds, 0.76; 95% CI, 0.64-0.91), whereas HDL(2) was not significant. No linear combination of the two subfractions was a better predictor of CHD than total HDL cholesterol alone. HDL(3) cholesterol was an independent predictor of incident CHD and may be more closely related to the development of CHD than HDL(2) cholesterol. The prediction of the risk of CHD from total HDL cholesterol alone could not be improved upon by measurement of the two HDL subfractions. In our view, the only way to improve our understanding of this situation is to measure both subfractions independently of each other and not to calculate one by subtraction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535746     DOI: 10.1016/s0021-9150(02)00361-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Separation of the principal HDL subclasses by iodixanol ultracentrifugation.

Authors:  Nicola L Harman; Bruce A Griffin; Ian G Davies
Journal:  J Lipid Res       Date:  2013-05-20       Impact factor: 5.922

2.  HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.

Authors:  Seth S Martin; Arif A Khokhar; Heidi T May; Krishnaji R Kulkarni; Michael J Blaha; Parag H Joshi; Peter P Toth; Joseph B Muhlestein; Jeffrey L Anderson; Stacey Knight; Yan Li; John A Spertus; Steven R Jones
Journal:  Eur Heart J       Date:  2014-06-30       Impact factor: 29.983

3.  Lower levels of total HDL and HDL3 cholesterol are associated with albuminuria in normoalbuminuric Type 1 diabetic patients.

Authors:  T Bulum; B Kolaric; L Duvnjak
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

4.  High-density lipoprotein subclass measurements improve mortality risk prediction, discrimination and reclassification in a cardiac catheterization cohort.

Authors:  Robert W McGarrah; Damian M Craig; Carol Haynes; Z Elaine Dowdy; Svati H Shah; William E Kraus
Journal:  Atherosclerosis       Date:  2016-01-11       Impact factor: 5.162

5.  Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.

Authors:  Marios K Georgakis; Rainer Malik; Christopher D Anderson; Klaus G Parhofer; Jemma C Hopewell; Martin Dichgans
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

6.  Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia.

Authors:  Adie Viljoen; Anthony S Wierzbicki
Journal:  Drug Healthc Patient Saf       Date:  2010-05-24

Review 7.  The independent relationship between triglycerides and coronary heart disease.

Authors:  Alan Morrison; John E Hokanson
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

8.  Prevalence and Correlates of Vitamin D Deficiency and Insufficiency in Luxembourg Adults: Evidence from the Observation of Cardiovascular Risk Factors (ORISCAV-LUX) Study.

Authors:  Ala'a Alkerwi; Nicolas Sauvageot; Georges Gilson; Saverio Stranges
Journal:  Nutrients       Date:  2015-08-13       Impact factor: 5.717

9.  Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype.

Authors:  Kirsten B Holven; Kjetil Retterstøl; Thor Ueland; Stine M Ulven; Marit S Nenseter; Marit Sandvik; Ingunn Narverud; Knut E Berge; Leiv Ose; Pål Aukrust; Bente Halvorsen
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

Review 10.  High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk.

Authors:  Anouar Hafiane; Jacques Genest
Journal:  BBA Clin       Date:  2015-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.